118
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Long-Term Efficacy and Safety of Subconjunctival/Perilesional 5-Fluorouracil Injections for Ocular Surface Squamous Neoplasia

& ORCID Icon
Pages 5659-5665 | Published online: 22 Dec 2020

References

  • LeeGA, HirstLW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429–450. doi:10.1016/S0039-6257(05)80054-27660300
  • GichuhiS, SagooMS, WeissHA, BurtonMJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health. 2013;18:1424–1443. doi:10.1111/tmi.1220324237784
  • YousefYA, FingerPT. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology. 2012;119:233–240. doi:10.1016/j.ophtha.2011.08.00522189448
  • AtallahM, JoagM, GalorA, et al. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases. Ocul Surf. 2017;15:688–695. doi:10.1016/j.jtos.2017.03.00328347855
  • Zarei-GhanavatiM, MousaviE, NabaviA, et al. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b. Ocul Surf. 2018;16:235–241. doi:10.1016/j.jtos.2017.12.00329306088
  • HabibalahiA, BalaC, AllendeA, AnwerAG, GoldysEM. Novel automated non invasive detection of ocular surface squamous neoplasia using multispectral autofluorescence imaging. Ocul Surf. 2019;17:540–550. doi:10.1016/j.jtos.2019.03.00330904597
  • Sayed-AhmedIO, PaliouraS, GalorA, KarpCL. Diagnosis and medical management of ocular surface squamous neoplasia. Expert Rev Ophthalmol. 2017;12:11–19. doi:10.1080/17469899.2017.126356728184236
  • SunY, HuaR. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections. Drug Des Devel Ther. 2019;13:1323–1334. doi:10.2147/DDDT.S191161
  • LiuZ, KarpCL, GalorA, Al BayyatGJ, JiangH, WangJ. Role of optical coherence tomography angiography in the characterization of vascular network patterns of ocular surface squamous neoplasia. Ocul Surf. 2020;18:926–935. doi:10.1016/j.jtos.2020.03.00932344147
  • TheotokaD, MorkinMI, NaranjoA, DubovySR, KarpCL. Spontaneous regression of ocular surface squamous neoplasia: possible etiologic mechanisms in cancer resolution. Ocul Surf. 2020;18:351–353. doi:10.1016/j.jtos.2020.03.00132169482
  • ParrozzaniR, FrizzieroL, TrainitiS, et al. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101:1094–1099. doi:10.1136/bjophthalmol-2016-30921927941046
  • CicinelliMV, MarcheseA, BandelloF, ModoratiG. Clinical management of ocular surface squamous neoplasia: a review of the current evidence. Ophthalmol Ther. 2018;7:247–262. doi:10.1007/s40123-018-0140-z30030703
  • SinghS, MittalR, GhoshA, TripathyD, RathS. High-resolution anterior segment optical coherence tomography in intraepithelial versus invasive ocular surface squamous neoplasia. Cornea. 2018;37:1292–1298. doi:10.1097/ICO.000000000000168029985794
  • JoagMG, SiseA, MurilloJC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123:1442–1448. doi:10.1016/j.ophtha.2016.02.03427030104
  • GichuhiS, MachariaE, KabiruJ, et al. Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2016;4:e378–e385. doi:10.1016/S2214-109X(16)30052-327198842
  • ElhamakyTR, ElbarkyAM. AS-OCT guided treatment of diffuse conjunctival squamous cell carcinoma with resection, amniotic membrane graft and topical mitomycin C. Clin Ophthalmol. 2019;13:2269. doi:10.2147/OPTH.S22939931819351
  • Al BayyatG, Arreaza-KaufmanD, VenkateswaranN, GalorA, KarpCL. Update on pharmacotherapy for ocular surface squamous neoplasia. Eye Vis. 2019;6:1–2. doi:10.1186/s40662-019-0150-5
  • SepulvedaR, Pe’erJ, MidenaE, SeregardS, DuaHS, SinghAD. Topical chemotherapy for ocularsurface squamous neoplasia: current status. Br J Ophthalmol. 2010;94:532–535.19776089
  • NanjiAA, SayyadFE, KarpCL. Topical chemotherapy for ocular surface squamous neoplasia. Curr Opin Ophthalmol. 2013;24:336–342. doi:10.1097/ICU.0b013e3283622a1323680759
  • KarpCL, GalorA, ChhabraS, BarnesSD, AlfonsoEC. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117:2241–2246. doi:10.1016/j.ophtha.2010.03.05220619462
  • ReynoldsJE, MartindaleW. Martindale: The Extra Pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society; 1996:572–575.
  • VenkateswaranN, MercadoC, GalorA, KarpCL. Comparison of topical 5-fluorouracil and interferon alfa-2b as primary treatment modalities for ocular surface squamous neoplasia. Am J Ophthalmol. 2019;199:216–222. doi:10.1016/j.ajo.2018.11.00730471241
  • ThomasBJ, GalorA, NanjiAA, et al. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia. Ocul Surf. 2014;12:46–58. doi:10.1016/j.jtos.2013.11.00124439046
  • OngSS, VoraGK, GuptaPK. Anterior segment imaging in ocular surface squamous neoplasia. J Ophthalmol. 2016;5435092. doi:10.1155/2016/543509227800176
  • ChauguleSS, ParkJ, FingerPT. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: is surgery necessary? Indian J Ophthalmol. 2018;66:55–60. doi:10.4103/ijo.IJO_590_1729283124
  • MiyashitaH, TagawaS, TakedaH, HigashideT, SugiyamaK. Comparison between stereo angiographic findings and histopathologic findings in endotoxin-induced uveitis. Curr Eye Res. 2009;34:536–542. doi:10.1080/0271368090293616319899966